Within-Host Evolution of SARS-CoV-2in a B-Cell Depleted Patient With Successful Treatment
Journal of Korean Medical Science
;
: e175-2023.
Article
in English
| WPRIM
| ID: wpr-976946
ABSTRACT
Prolonged viral shedding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in an immunocompromised host is a challenge as the treatment and infection control for chronic coronavirus disease 2019 infection is not well established and there is a potential risk of new variants emerging. A 48-year-old woman who underwent chemotherapy, including rituximab and steroid, had reactivation of SARS-CoV-2 68 days after the virus was first detected. She successfully recovered after receiving convalescent plasma and intravenous immunoglobulin. Genomic analysis demonstrated that viruses collected from the nasopharyngeal specimens at day 0 and day 68 had 18 different nucleotide mutations, implying within-host evolution after in-depth epidemiologic investigation.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
English
Journal:
Journal of Korean Medical Science
Year:
2023
Type:
Article
Similar
MEDLINE
...
LILACS
LIS